Czechia· CZ-0222660
ELEBRATO ELLIPTA
A vilanterol, umeclidinium bromid und fluticason furoat product containing fluticasone furoate + umeclidinium bromide + vilanterol trifenatate, registered in Czechia by GlaxoSmithKline Trading Services Limited, Dublin. The same ATC class is registered in 11 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Vilanterol, umeclidinium bromid und fluticason furoat is registered in 11 of 19 countries.
Countries holding a registration under ATC R03AL08 (vilanterol, umeclidinium bromid und fluticason furoat), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 7 of them publish a price we can compare per daily dose
Vilanterol, umeclidinium bromid und fluticason furoat · ATC R03AL08
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- FLUTICASONE FUROATE + UMECLIDINIUM BROMIDE + VILANTEROL TRIFENATATE
- Manufacturer
- GlaxoSmithKline Trading Services Limited, Dublin
- Country
- Czechia (CZ)
- ATC code
- R03AL08
- ATC class
- Vilanterol, Umeclidinium bromid und Fluticason furoat
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vilanterol, umeclidinium bromid und fluticason furoat in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bbeea9b1-a500-4901-8b08-1d1836637102 GET /v1/drugs/bbeea9b1-a500-4901-8b08-1d1836637102?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INH PLV DOS",
"source": "sukl",
"strength": "92MCG/55MCG/22MCG",
"pack_size": "1X30DÁV",
"substance": "FLUTICASONE FUROATE + UMECLIDINIUM BROMIDE + VILANTEROL TRIFENATATE",
"cz_kod_sukl": "0222660",
"product_type": "CH",
"substance_codes": "17738,19711,20312",
"registration_state": "R",
"registration_number": "EU/1/17/1237/002"
}See everything about vilanterol, umeclidinium bromid und fluticason furoat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.